Recent News

• 03.31.2026 - LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year
• 02.18.2026 - LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
• 01.21.2026 - DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE
• 01.20.2026 - LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
• 12.23.2025 - LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
• 12.18.2025 - Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Recent Filings

• 03.20.2026 - 8-K Current report
• 03.10.2026 - 8-K Current report
• 02.18.2026 - 8-K Current report
• 02.18.2026 - EX-99.1 EX-99.1
• 12.31.2025 - 8-K Current report
• 12.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.23.2025 - 8-K Current report
• 12.23.2025 - EX-99.1 EX-99.1
• 12.22.2025 - EX-99.1 EX-99.1